DNAprint Genomics (DNAG)

[dgplexus]

Obtaining new funding, on the best terms possible, takes significant time. Especially when the credit markets are so tight, as they are now, and when DNAG is so sensitized to funding terms (after Dutchess.)

If DNAG hasn't obtained all the funding they're looking for, yet, I'm sure they are working on it. Just give them some time. Meanwhile, who cares how low the stock goes? Is anyone really planning on selling now, before funding news and the intended buybacks come? I can only speak for myself, but there's no way I'd sell now. Actually, if the stock price drops further, that just makes it an even better buy, for anyone still looking to average down their price per share and increase their holdings, and also makes it easier for the company to execute meaningful buybacks (in the sense of reducing outstanding shares.) Just my two cents.